• Safety and efficacy of smaller drops has been shown to be equivalent or superior to larger drops

• Side effect profile of topical eye medications may increase in a volume-dependent manner

• These can lead to serious complications, especially in pediatric populations

• The capacity of the human eye is 7-10 μL

• Nanodropper significantly reduces drop volume by over 60% on average

• Never produces drops less than 10 μL

• Tested with solutions, suspension, and emulsion

• Efficacy of the Nanodropper Device on Pupillary Dilation

• Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients

• Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension

• Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma

• FDA Class I medical device, 510(k) exempt

  • Cleared to sell in the US

• Manufactured, assembled, packaged, and sterilized in US

  • ISO Class 7 and 8 cleanrooms

• Certifications: ISO 13485:2016, ISO 17665, ISO 9001-2015

• HIPAA compliant practices verified

• Department of Defense-approved sole source acquisition contractor for US federal entities

Nanodropper is a one-size-fits-most for a specific bottle type. Please visit the page linked below to ensure that Nanodropper is compatible with the formulation in question.